HOME >> MEDICINE >> NEWS
Is there a way to derail the children's 'Allergy March'?

is often pre-determined by one's genetic makeup. Childhood atopy is the genetically-determined state of hypersensitivity to environmental allergens. Type I allergic reactions are associated with the IgE antibody and a group of diseases, principally asthma, hay fever and atopic dermatitis. The condition is characterized by a noted increase in IgE levels. The good news is that the s-IgE test is available to identify the atopic child, enabling the development of a treatment plan.

Age and the Allergy March

As children develop, so to can the likelihood of common childhood diseases related to atopy. For example, eczema is most likely to occur between birth and three months of age; gastrointestinal distress is most prevalent during the second year; upper respiratory distress generally manifests itself between ages three and seven; and asthma's onset is most likely to occur when a youngster is between 7-15 years old.

Diseases in the Early Years

The most common diseases requiring treatment include:

Eczema: Eczema (atopic dermatitis) is a chronic itch that develops into a rash. Allergy commonly underlies itch, with 30 percent of all skin disorder cases in toddlers being allergy-induced eczema. Research has established a link between IgE and food allergen-induced atopic dermatitis with food allergy the root cause in one-third to one-half of all childhood cases. This is not surprising, given hidden ingredients in commercial foods, the presence of preservatives and stabilizers, as well as artificial colors and flavors and the early introduction of solid foods to infants.

The symptoms are intense itching and skin cutaneous reactivity, and a spreading of rash-like symptoms. This condition can also be caused by immunodeficiency, metabolic disease, neoplastic disease, infection and infestation, and dermatitis. However, at the first sign of these symptoms, the specific IgE blood test is appropriate
'"/>

Contact: Donna Krupa
djkrupa1@aol.com
703-527-7357
American Association for Clinical Chemistry
21-Jul-2003


Page: 1 2 3 4

Related medicine news :

1. Where theres smoke, theres money
2. Is there a relationship between repeated pregnancies and increased cardiovascular disease?
3. Is there an alternative to expensive testing for HIV diagnosis and AIDS management?
4. Joint-custody arrangements good for children of divorce -- but only if there is no parental conflict
5. Is there a neurologist on this flight?
6. Bird brains take heart-our feathered friends are no slouch at cognition
7. Pushy parents can be bad for their childrens health
8. Study: Eye contact triggers threat signals in autistic childrens brains
9. $4 million grant boosts University of Michigan campaign for a new childrens hospital
10. Concerns over the future of childrens health care in British general practice
11. New findings on patient safety at childrens hospitals

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: there way derail the children Allergy March

(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... According to ... been developed that changes color when subjected to an impact force that is great ... be implemented in helmets or other sporting equipment so that coaches or officials would ...
(Date:9/4/2015)... ... September 04, 2015 , ... According to an article published August ... Association presented data showing that it is safe for pregnant women to undergo local ... had undergone local anesthesia with a group that hadn’t, researchers were able to determine ...
(Date:9/4/2015)... ... September 04, 2015 , ... On ... has effectively doubled the size of its annual health tech innovation program. Now ... digital health startups to compete for cash and prizes to advance their technologies ...
(Date:9/4/2015)... , ... September 04, 2015 , ... With TransCel from ... mouse all within Final Cut Pro X. With TransCel users have full control over ... width, background color, speed method, frame color, inner color, text, and more. With TransCel ...
(Date:9/4/2015)... ... 2015 , ... Mile High Connects today releases “First and Last Mile Connections,” ... sidewalks, bike paths, and other vital supports severely limit access to public transportation for ... dollars to expand public transit, there’s very little support for safe and convenient access ...
Breaking Medicine News(10 mins):Health News:New Article on Head Injury Detection Technology Highlights Implications for Head Injury Detection in Sports, says The Law Offices of Burg & Brock 2Health News:Recent Study on Dental Care During Pregnancy Demonstrates How Preventative Dental Care Really is for Everyone, Says Medical Center Dental Care 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 3Health News:Pixel Film Studios Releases TransCel, a New FCPX Transition 2Health News:Missed Connections in Metro Denver Transit 2
(Date:9/4/2015)... , Sept. 4, 2015  Janssen Research & ... and Drug Administration (FDA) has accepted for Priority ... as a treatment for patients with multiple myeloma ... (PI) and an immunomodulatory agent (IMiD), or who ... therapy, including a PI and an IMiD. This ...
(Date:9/4/2015)... -- Fair Rate Funding, a lawsuit funding firm located in ... increase in lawsuit filings in connection with the blood thinning ... Philadelphia Court of Common Pleas has ... Louisiana multi---district litigation (MDL), located in ... Louisiana , the filings are also on the ...
(Date:9/4/2015)... HILL, N.C. , Sept. 4, 2015 /PRNewswire/ ... Liaisons (MSLs) and other Field-Based Medical Specialists (FBMS) ... key opinion leaders, and thought leaders in critical ... effectiveness of their field-based teams, companies are expanding ... order to align countries with corporate objectives and ...
Breaking Medicine Technology:U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 2U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 3U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 4U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 5U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 6U.S. FDA Grants Priority Review to Janssen for Daratumumab as a Treatment for Multiple Myeloma 7Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 2Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 3New Study Presents Tactics and Insights on How to Effectively Globalize Medical Science Liaison Programs in the Pharmaceutical Industry 2
Cached News: